TOWARDS PERSONALIZED MEDICINE USING A NOVEL PRECLINICAL MODEL: IDENTIFYING DARATUMUMAB AS EFFECTIVE TREATMENT FOR MULTIPLE MYELOMA

被引：0
|
作者：
Noort, W. [1 ]
Groen, R. [1 ]
Raymakers, R. [1 ]
Prins, H. [1 ]
Aalders, L. [1 ]
Hofhuis, F. [1 ]
van Kessel, B. [1 ]
Moerer, P. [1 ]
Rozemuller, H. [1 ]
de Bruijn, J. [2 ]
de Weers, M. [3 ]
Schuringa, J. [1 ]
Parren, P. [3 ]
Lokhorst, H. [1 ]
Mutis, T. [1 ]
Martens, A. [1 ]
机构：
[1] Univ Med Ctr, Utrecht, Netherlands
[2] Queen Mary Univ London, Sch Engn & Mat Sci, London, England
[3] Genmab BV, Utrecht, Netherlands
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1075
引用
收藏
页码：438 / 438
页数：1
相关论文
共 50 条
  • [31] Using ncRNAs as Tools in Cancer Diagnosis and Treatment-The Way towards Personalized Medicine to Improve Patients' Health
    Piergentili, Roberto
    Basile, Giuseppe
    Nocella, Cristina
    Carnevale, Roberto
    Marinelli, Enrico
    Patrone, Renato
    Zaami, Simona
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [32] Preclinical Evaluation of CRx-501, a Potent Selective A2A Agonist as a Novel Drug Candidate for the Treatment of Multiple Myeloma
    Rickles, Richard J.
    Pierce, Laura
    Giordano, Thomas
    Avery, William
    Farwell, Melissa
    Crowe, David
    Tam, Winnie F.
    Chen, Mei
    Kansra, Vikram
    McMillin, Douglas W.
    Anderson, Kenneth C.
    Mitsiades, Constantine
    Lee, Margaret S.
    BLOOD, 2008, 112 (11) : 100 - 100
  • [33] TREATMENT PATTERNS OF PATIENTS WITH MULTIPLE MYELOMA IN SOUTH KOREA USING A COMMON DATA MODEL
    Jung, E.
    Suh, H. S.
    VALUE IN HEALTH, 2024, 27 (12) : S327 - S327
  • [34] Preclinical study of Targeted Alpha Therapy using 211At-labeled phenylalaline derivative in a syngeneic Multiple Myeloma model
    Gaschet, J.
    Echeynne, R.
    Chouin, N.
    Gazzola, S.
    Guerard, F.
    Gouard, S.
    Marionnaud-Lambot, S.
    Maubert, A.
    Alliot, C.
    Hofgaard, P. O.
    Bogen, B.
    Yan, E.
    Haddad, F.
    Kraeber-Bodere, F.
    Wheatcroft, M.
    Gestin, J.
    Cherel, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S39 - S40
  • [35] ZEBRAFISH PATIENT DERIVED XENOGRAFT MODEL OF COLON CANCER AS PERSONALIZED MEDICINE TOOL TO PREDICT THE MOST EFFECTIVE TREATMENT STRATEGY.
    Di Franco, G.
    Usai, A.
    Piccardi, M.
    Cateni, P.
    Cremolini, C.
    Pollina, L.
    Raffa, V.
    Morelli, L.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (05)
  • [36] Antitumor Activity in a Human Multiple Myeloma (MM) Model Using Sorafenib, Bortezomib, and Dexamethasone Treatment
    Scholer, Julia
    Wider, Dagniar
    Pfeifer, Dietmar
    Wagner, Martin
    Fiebig, Heinz-Herbert
    Engelhardt, Monika
    BLOOD, 2008, 112 (11) : 606 - 606
  • [37] Preclinical pharmacology and safety of RO7297089, a novel anti-BCMA/CD16a bispecific antibody for the treatment of multiple myeloma
    Kakiuchi-Kiyota, Satoko
    Schutten, Melissa M.
    Adedeji, Adeyemi O.
    Cai, Hao
    Hendricks, Robert
    Liu, Luna
    Cohen, Sivan
    Fullerton, Aaron M.
    Corr, Nicholas
    Yu, Lanlan
    Nagata, Denise de Almeida
    Zhong, Shelly
    Dillon, Michael
    Spiess, Christoph
    Leong, Steve R.
    Zheng, Bing
    Wingert, Susanne
    Reusch, Uwe
    Knackmuss, Stefan
    Ross, Thorsten
    Polson, Andrew
    Ovacik, Ayse M.
    CANCER RESEARCH, 2020, 80 (16)
  • [38] Novel In Vivo Model of Multiple Myeloma Bone Disease Using β-Tricalcium Phosphate Artificial Bone Grafts
    Koulnis, Miroslav
    Eda, Homare
    Santo, Loredana
    Siu, Ka Tat
    Ramachandran, Janani
    Panaroni, Cristina
    Tanaka, Takaaki
    Raje, Noopur S.
    BLOOD, 2015, 126 (23)
  • [39] The role of angiogenin on multiple myeloma (MM) cell migration and invasion using a novel in vivo model.
    Chen, HM
    Yang, HH
    Guangxu, S
    Yan, XM
    Campbell, R
    Berenson, JR
    BLOOD, 2003, 102 (11) : 379B - 379B
  • [40] Identifying the Pathogenicity of a Novel NPRL3 Missense Mutation Using Personalized Cortical Organoid Model of Focal Cortical Dysplasia
    Lu, Rongrong
    Xu, Ying
    Li, Hao
    Xiong, Man
    Zhou, Wenhao
    Feng, Weijun
    Zhao, Rui
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2024, 75 (01)
12345